Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1

3(50.0%)

Phase 1

1(16.7%)

N/A

1(16.7%)

Phase 2

1(16.7%)

6Total

Early Phase 1(3)

Phase 1(1)

N/A(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07546461Not Yet Recruiting

A Multiphase Operational and Environmental Assessment of Lunar Surface Habitation, Lunar Gateway Transit Systems, and Acceleration Pathways for Sustained Human Habitation of the Martian Surface

Role: lead

NCT07472023Early Phase 1Enrolling By Invitation

Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing Loss

Role: lead

NCT07382804Not ApplicableEnrolling By Invitation

Mobile Behavioral Activation Program With Wearable Sensors and Secure Activity Verification

Role: lead

NCT07321028Early Phase 1Enrolling By Invitation

Evaluation of In-Vitro Cryo Therapeutic Protocols on Human Cell Samples (TWH-CRYO-001)

Role: lead

NCT07221565Phase 1Enrolling By Invitation

Quantum-Synaptic Immunotherapy Mapping Using Low-Frequency Electromagnetic Resonance and Machine Learning-Based Cytokine Forecasting

Role: lead

NCT07209527Early Phase 1Enrolling By Invitation

Truway Diagnostic Tools in Primary Care

Role: lead

NCT07214896Phase 2Enrolling By Invitation

Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

Role: lead

NCT07217730Enrolling By Invitation

Healthcare Integrity & Anti-Fraud Enforcement

Role: lead

All 8 trials loaded